Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47.9M
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
54.6M
-
Shares change
-
+8.3M
-
Total reported value, excl. options
-
$2.22B
-
Value change
-
+$337M
-
Number of buys
-
91
-
Number of sells
-
-77
-
Price
-
$40.57
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q1 2017
199 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q1 2017.
HAEMONETICS CORP - Common Stock (HAE) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.6M shares
.
Largest 10 shareholders include BlackRock Inc. (6.29M shares), VANGUARD GROUP INC (4.69M shares), WELLINGTON MANAGEMENT GROUP LLP (4.19M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.47M shares), WELLS FARGO & COMPANY/MN (2.55M shares), VICTORY CAPITAL MANAGEMENT INC (2.39M shares), FULLER & THALER ASSET MANAGEMENT, INC. (2.21M shares), Neuberger Berman Group LLC (2.01M shares), DIMENSIONAL FUND ADVISORS LP (1.7M shares), and HealthCor Management, L.P. (1.6M shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.